RB

Rusheng Bao

Active Director Director DIN 07873420
DIN 07873420 First appointment Aug 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value •••• Premium profile

About Rusheng Bao

Data last updated:

Rusheng Bao is a Director at Hifil Chemicals Private Limited (since 2017). The company operates in Pharma. Hifil Chemicals Private Limited reported revenue of ₹1.7 Lakh (FY 2025).

DIN 07873420
Primary Designation Director
Industry Pharma
First Appointment 31 Aug 2017
Oldest Company Age 16 yrs
Largest company Hifil Chemicals Private Limited · ₹1.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hifil Chemicals Private Limited U24100MH2009PTC198057
Director31 Aug 20172009₹1.7 Lakh (FY 2025)Active

Board colleagues of Rusheng Bao

NameDINCompanyDesignation
Atul Kumar Gupta07951726Hifil Chemicals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hifil Chemicals Private Limited
Premium access

Shareholding and investment profile for Rusheng Bao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rusheng Bao

Rusheng Bao currently holds 1 directorship: Hifil Chemicals Private Limited (Director, since 31 Aug 2017, revenue ₹1.7 Lakh (FY 2025)).

Rusheng Bao was first appointed on 31 Aug 2017 as Director at Hifil Chemicals Private Limited.

The current boards of Rusheng Bao's companies include Atul Kumar Gupta (Hifil Chemicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available